Our Media - Pharmetheus at the cutting edge offset model-informed drug development
Latest content from Pharmetheus.
Pharmetheus at the cutting edge offset model-informed drug development
Pharmetheus featured in Pharma Tech Outlook magazine
January 14, 2021
Our CEO, Peter Milligan, has been interviewed by the Pharma Tech Outlook magazine. Read more about how cutting-edge methods and tools help change the model-informed drug development landscape of the pharmaceutical industry, from early clinical trials to drug approval.
